{"schema_version":"secwatch.filing_event.v1","accession":"0001006837-26-000038","form_type":"8-K","ticker":"VATE","cik":"0001006837","company_name":"INNOVATE Corp.","filed_at":"2026-05-14T20:11:26+00:00","discovered_at":"2026-05-14T20:13:01.306886+00:00","generated_at":"2026-05-14T20:54:43.213490+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"INNOVATE Q1 revenue up 33% to $364.8M; net loss narrows to $17.2M; adjusted EBITDA rises 174% to $19.7M","bullets":["Infrastructure segment revenue $357.9M (+35.1% YoY); DBMG reported backlog $1.6B, adjusted backlog $1.8B.","Life Sciences: MediBeacon received CE mark under EU MDR for Transdermal GFR Monitor and Reusable Sensor.","Spectrum revenue $5.3M (down 14.5% YoY) on advertising softness; collaborative trials underway with major carrier.","Net loss per diluted share improved to ($1.29) from ($1.89) YoY; Total Adjusted EBITDA $19.7M vs $7.2M.","Cash and cash equivalents $134.6M at March 31, 2026; non-operating corporate cash $2.5M."],"urls":{"canonical":"https://secwatch.observer/filing/0001006837-26-000038","json":"https://secwatch.observer/filing/0001006837-26-000038.json","markdown":"https://secwatch.observer/filing/0001006837-26-000038.md","text":"https://secwatch.observer/filing/0001006837-26-000038.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1006837/000100683726000038/0001006837-26-000038-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1006837/000100683726000038/vate-20260514.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-14T20:54:43.213490+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"f093856b0b6a09b55251dc7a605555194fe52aa5","claim":"INNOVATE Corp. reported the three months ended March 31, 2026 results: revenue $364.8 million, net income $(17.2) million, EPS $(1.29).","evidence_excerpt":"to gain support, but still waiting for FCC approvals. First Quarter 2026 Financial Highlights • Revenue: For the first quarter of 2026, INNOVATE's consolidated revenue was $364.8 million, an increase of 33.0%, compared to $274.2 million for the prior year quarter. The increase was driven primarily by our Infrastructure segment, which was partially offset by","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1006837/000100683726000038/0001006837-26-000038-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the three months ended March 31, 2026"},{"label":"Revenue","value":"$364.8 million"},{"label":"Net income","value":"$(17.2) million"},{"label":"EPS","value":"$(1.29)"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}